Price for prescription drugs subject to the Medicare Drug Price Negotiation Program established.

Minnesota House Bill 5156, introduced on May 17, 2026, aimed to establish a program that would allow the state to negotiate prices for prescription drugs, similar to the federal Medicare Drug Price Negotiation Program. The bill was sponsored by 25 Democratic representatives, including Rep. Michael Howard and Rep. Leigh Finke. It was referred to the House Health Finance and Policy Committee but did not progress further and died in committee. ([legiscan.com](https://legiscan.com/MN/bill/HF5156/2025?utm_source=openai))

Positive media analysis is being generated.

Without direct media coverage of Minnesota's HF5156, it's challenging to assess specific criticisms. However, similar proposals in other states have faced opposition from pharmaceutical companies and some policymakers concerned about potential impacts on the pharmaceutical market and drug availability.